comparemela.com
Home
Live Updates
TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2 : comparemela.com
TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Related Keywords
Denmark ,
Texas ,
United States ,
Hellerup ,
Hovedstaden ,
Gwendolyn Schanker ,
Rasmus Toft Kehler ,
Corey Davis ,
Michael Saag ,
Safety Management Committee ,
School Of Medicine ,
Drug Administration ,
Nasdaq ,
Film Freezing Technology Platform ,
Lifesci Communications ,
Pharmaceuticals Scientific Advisory Board ,
Pharmaceuticals Inc ,
Inhaled Niclosamide Estimated ,
Produce Concentrations ,
Complete Phase ,
Pharmacokinetic Data ,
Inhaled Niclosamide ,
Thin Film Freezing ,
Scientific Advisory ,
Glenn Mattes ,
Chief Operating Officer ,
Single Ascending Dose ,
Multiple Ascending Dose ,
Thin Film Freezing Technology Platform ,
Matrix Particle ,
Voriconazole Inhalation Powder ,
Tacrolimus Inhalation ,
Relations Contact ,
Coronavirus Pandemic ,
Technology ,
Science ,
Health ,
Business ,
Globe Newswire ,
Patents ,
comparemela.com © 2020. All Rights Reserved.